Jobs / United States / Pfizer INC

Sr. Manager, Lung Portfolio Marketing

Pfizer INC · 🇺🇸 4 Locations

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Pfizer INC paid sponsored hires in similar roles3 certified filings for “SENIOR MANAGER, STATISTICAL PROGRAMMING” (Statisticians) in CA: $171k–$214k, median $208k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Pfizer INC

40 H-1B filings certified since Oct 2025

The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →

About the role

ROLE SUMMARY The Lung cancer portfolio is one of the fastest growing portfolios in Pfizer Oncology and includes the following brands: LORBRENA, BRAFTOVI/MEKTOVI Lung and XALKORI. Lung cancer is the most common cancer, and LORBRENA, our ALK+ inhibitor has been prescribed to over 12,000 patients since launching in the US in 2018. At ASCO 2024, the unprecedented 5-year follow analysis of the pivotal Phase 3 CROWN trial was presented and published. This practice-changing data is expected to solidify LORBRENA’s position in treating patients with ALK+ metastatic non-small cell lung cancer (NSCLC). BRAFTOVI+MEKTOVI is indicated for adult mNSCLC patients with a BRAF V600E mutation. Recent updates to the PHAROS study make this combination therapy also one of the growth drivers for the lung portfolio.   The Sr Manager, Lung Portfolio Marketing position will report to the US Lung Team Lead and will be responsible for developing a variety of HCP and Patient strategies and tactics, including leading the planning and execution of congresses and speaker programs across the portfolio. Activities associated with this position include strategic marketing, tactics planning, data & analytics. The Sr Manager will work closely with internal and external partners, including, sales, market insights, Regulatory, Legal, Medical Affairs, TLELs, Advocacy, other members of the brand team, and agencies.   ROLE RESPONSIBILITIES • Develop strategies and tactics in collaboration with LORBRENA and BRAFTOVI/MEKTOVI HCP and Patient leads to ensure continued growth of the portfolio • Lead Congress planning and execution for Lung Portfolio - serve as US Lead for all regional/national/global congresses • Lead identification and development of Lung Speaker Bureau and manage execution and training of all speaker programs • Manage co-pay and vouchers program for LORBRENA and XALKORI • Continuously measure the impact of marketing initiatives, generating early learning, and driving continuous improvement to achieve budget • Oversee Print Inventory Management for the Lung portfolio • Own all promotional projects through the Medical, Legal and Regulatory review process and ensure that materials and programs are compliant • Lead efforts to coordinate and align work across cross-functional and marketing colleagues, agencies, and other stakeholders to ensure strategic and tactical alignment and execution for all personal promotional materials • Propose and manage detailed budget; manage outside agencies - develop project briefs, execute projects, and manage timelines, while ensuring consistency with product positioning, brand guidelines, company goals, and ethics   BASIC QUALIFICATIONS Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact. • Bachelor’s Degree required; advanced degree preferred • 6+ years pharmaceutical/biotech marketing experience; MBA/MS with 5+ years • Previous in-line US/global Marketing experience and/or understanding of advanced lung cancer landscape preferred • Performance in prior positions demonstrates that candidate is well-prepared to advance their Marketing career beyond this role • Demonstrated ability to develop actionable insights from complex clinical data and market research • Strong leadership and ability to influence across functional stakeholders, including senior executives, to set direction, align work efforts, and ensure outstanding execution • Strong collaboration skills, working effectively with both internal teams and co-promotion partner • Excellence in additional professional competencies includi

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-03 Last confirmed: 2026-10-03 How our data works → Report this job

Similar opportunities